Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1957 1
1960 1
1972 1
1973 1
1974 1
1976 1
1979 2
1980 2
1981 4
1982 11
1983 11
1984 15
1985 12
1986 11
1987 15
1988 13
1989 9
1990 11
1991 5
1992 11
1993 20
1994 27
1995 24
1996 28
1997 30
1998 44
1999 49
2000 42
2001 51
2002 71
2003 102
2004 97
2005 143
2006 147
2007 155
2008 182
2009 240
2010 266
2011 270
2012 331
2013 386
2014 446
2015 471
2016 531
2017 568
2018 618
2019 640
2020 766
2021 866
2022 708
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

7,623 results
Results by year
Filters applied: . Clear all
Page 1
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway.
Guo E, Xiao R, Wu Y, Lu F, Liu C, Yang B, Li X, Fu Y, Wang Z, Li Y, Huang Y, Li F, Wu X, You L, Qin T, Lu Y, Huang X, Ma D, Mills GB, Sun C, Chen G. Guo E, et al. Among authors: ma d. J Exp Med. 2022 Jan 3;219(1):e20210789. doi: 10.1084/jem.20210789. Epub 2021 Nov 26. J Exp Med. 2022. PMID: 34825915 Free PMC article.
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Wang ZX, Cui C, Yao J, Zhang Y, Li M, Feng J, Yang S, Fan Y, Shi J, Zhang X, Shen L, Shu Y, Wang C, Dai T, Mao T, Chen L, Guo Z, Liu B, Pan H, Cang S, Jiang Y, Wang J, Ye M, Chen Z, Jiang D, Lin Q, Ren W, Wang J, Wu L, Xu Y, Miao Z, Sun M, Xie C, Liu Y, Wang Q, Zhao L, Li Q, Huang C, Jiang K, Yang K, Li D, Liu Y, Zhu Z, Chen R, Jia L, Li W, Liao W, Liu HX, Ma D, Ma J, Qin Y, Shi Z, Wei Q, Xiao K, Zhang Y, Zhang Y, Chen X, Dai G, He J, Li J, Li G, Liu Y, Liu Z, Yuan X, Zhang J, Fu Z, He Y, Ju F, Liu Z, Tang P, Wang T, Wang W, Zhang J, Luo X, Tang X, May R, Feng H, Yao S, Keegan P, Xu RH, Wang F. Wang ZX, et al. Among authors: ma d. Cancer Cell. 2022 Mar 14;40(3):277-288.e3. doi: 10.1016/j.ccell.2022.02.007. Epub 2022 Mar 3. Cancer Cell. 2022. PMID: 35245446 Clinical Trial.
CircOGDH Is a Penumbra Biomarker and Therapeutic Target in Acute Ischemic Stroke.
Liu Y, Li Y, Zang J, Zhang T, Li Y, Tan Z, Ma D, Zhang T, Wang S, Zhang Y, Huang L, Wu Y, Su X, Weng Z, Deng D, Tsang CK, Xu A, Lu D. Liu Y, et al. Among authors: ma d. Circ Res. 2022 Mar 18;130(6):907-924. doi: 10.1161/CIRCRESAHA.121.319412. Epub 2022 Feb 22. Circ Res. 2022. PMID: 35189704
Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2).
Xu J, Li Y, Fan Q, Shu Y, Yang L, Cui T, Gu K, Tao M, Wang X, Cui C, Xu N, Xiao J, Gao Q, Liu Y, Zhang T, Bai Y, Li W, Zhang Y, Dai G, Ma D, Zhang J, Bai C, Huang Y, Liao W, Wu L, Chen X, Yang Y, Wang J, Ji S, Zhou H, Wang Y, Ma Z, Wang Y, Peng B, Sun J, Mancao C. Xu J, et al. Among authors: ma d. Nat Commun. 2022 Feb 14;13(1):857. doi: 10.1038/s41467-022-28408-3. Nat Commun. 2022. PMID: 35165274 Free PMC article. Clinical Trial.
Development of a Saliva-Optimized RT-LAMP Assay for SARS-CoV-2.
Yu AD, Galatsis K, Zheng J, Le JQ, Ma D, Perlman S, Rosbash M. Yu AD, et al. Among authors: ma d. J Biomol Tech. 2021 Sep;32(3):102-113. doi: 10.7171/jbt.21-3203-005. J Biomol Tech. 2021. PMID: 35027868 Free PMC article.
Growth Factors and Their Roles in Multiple Sclerosis Risk.
Lu H, Wu PF, Ma DL, Zhang W, Sun M. Lu H, et al. Among authors: ma dl. Front Immunol. 2021 Oct 21;12:768682. doi: 10.3389/fimmu.2021.768682. eCollection 2021. Front Immunol. 2021. PMID: 34745143 Free PMC article.
7,623 results